To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
When necessary, the turning on of your stress physiologic response can save your life. Maternal stress can affect the fetus so it engages survival strategies. Socioeconomic inequality in early life impacts adults in various ways. Stress in infancy can be positive, such as when taking the first step, tolerable, such as when a family member is seriously ill but supportive adults are present, or toxic, when there is strong, frequent, or prolonged activation in the absence of buffers, which can have lifelong effects. Stress impacts various cellular organelles and produces inflammation. Cumulative chronic stresses produce wear and tear, limiting effective activation when needed to save your life. Those lower down the socioeconomic gradient have poorer functioning organs and suffer more harmful effects of stress. Ever more common obesity can be related to increasing chronic stresses of modern life. Metabolic syndrome, the way energy is stored, is related to many chronic diseases today. Prenatal stress and low birthweight predispose children to this condition
Impaired autophagy has been implicated in the pathophysiology of neurodegenerative disorders, such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Consistent and replicated evidence indicate that Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) exert treatment and preventative effects across disparate neurologic and mental disorders, potentially through mechanisms involving autophagy. This systematic review examined the effects of GLP-1RAs on autophagy in cell and animal models of AD and PD, as a proof of concept, to determine if these agents can be repurposed for the prevention and treatment of neurodegenerative and other mental disorders.
Methods:
A systematic search on PubMed, Web of Science, and OVID (Medline, Embase, and APA PsycInfo databases) was conducted from inception to June 17, 2025. Screening was performed independently by two reviewers (MCS and IH) using predefined inclusion and exclusion criteria. Subsequently, a quality assessment was conducted.
Results:
The search yielded 142 studies, of which 14 were included. Across studies, GLP-1RAs (e.g., liraglutide, semaglutide, and exendin-4) autophagy-specific markers, including beclin-1, LC3-II/LC3-I, ATG7, ATG3, and LAMP1, while normalizing p62 levels.
Discussion:
In addition to promoting neurogenesis, neuroplasticity, and reducing inflammation, GLP-1RAs appear to modulate molecular and cellular systems contributing to autophagy, potentially mediating their broad therapeutic effects. Collectively, these studies present promising findings of GLP-1RAs for neurodegenerative and mental disorders; however, further studies are required to establish their translatability to human populations.
Genetic predisposition to obesity can stimulate an increase in adiposity throughout adulthood. However, the interaction between genetic factors and dietary habits may modify the genetic association with obesity. Thus, this study aimed to investigate the dietary patterns that influence the genetic risk of obesity in a Korean population using a large cohort study and genome-wide association study.
Design:
Prospective cohort study.
Setting:
The genetic risk score (GRS) was calculated based on six identified single nucleotide polymorphisms of the OTOL1, NMBR, DNAJB9, ASCC1, NT5C2, and FTO genes associated with obesity, as ascertained by body mass index. Dietary patterns were determined using food intake data from a food frequency questionnaire and factor analysis.
Participants:
This study included data from 8,458 adults aged 40-69 years from the Ansan and Ansung cohorts of the Korean Genome and Epidemiology Study.
Results:
The refined carbohydrate dietary pattern showed a significant inverse association with obesity in the highest GRS group with a non-significant interactive association (odds ratio [OR], 0.801; 95% confidence interval [CI], 0.662–‒0.969; P for trend = 0.0251, P for interaction = 0.571). However, participants with the highest refined carbohydrate dietary pattern score and highest GRS had an increased prevalence of obesity (OR: 1.288, 95% CI: 1.068‒1.554, P for trend = 0.0251) compared with the prevalence of those with the lowest dietary pattern score and GRS.
Conclusions:
Reducing refined carbohydrate consumption may be helpful for Korean adults with a greater genetic susceptibility to obesity.
Growing evidence supports early eating to control appetite and energy balance but there are few controlled studies to assess the amount and/or type of breakfast meal. This randomized, within-participant, diet intervention examined the effects of higher-fibre (HF) and higher-protein (HP) breakfasts in adults with overweight/obesity. Nineteen healthy adults consumed two randomized 28 day weight loss (WL) diets; as higher-fibre (HFWL) or higher protein (HPWL), with all food provided. Both WL diets were designed as 45%, 35% and 20% of calories to be consumed at the morning, afternoon and evening, respectively. The primary outcome was energy balance, analysed by body weight changes. The secondary outcomes were gut health (assessed by changes in faecal microbiota composition and microbial metabolite concentrations) and subjective appetite assessed with visual analogue scales (VAS). There was a diet effect on WL, with mean loss of -4.87 kg and -3.87 kg for the HFWL and HPWL diets, respectively (P=0.002). The HPWL diet was superior to the HFWL diet for suppressing subjective appetite (P=0.003). The faecal microbiota analysis showed beneficial groups of bacteria, including bifidobacteria, and the butyrate-producers Faecalibacterium and Roseburia, were significantly increased in proportional abundance on the HFWL diet. Breakfast composition has an important role in influencing subjective appetite with the higher-protein diet promoting greater feelings of satiety. The proportional abundance of putatively beneficial groups of gut microbiota was markedly higher on the fibre-enriched diet, which may be preferable for gut health.
Prenatal exposure to PUFA has been associated with child weight at birth and may have a persistent effect on adiposity development across childhood. Fish is the richest dietary source of n-3 PUFA, albeit few studies have investigated associations between maternal fish consumption during pregnancy and child weight. This study examines associations between maternal fish consumption and prenatal PUFA status (n-3 and n-6), with longitudinal measures of child weight in the high fish-eating Seychelles Child Development Study Nutrition Cohort 2. Maternal fish consumption during pregnancy was assessed using a Fish Use Questionnaire administered at 28 weeks’ gestation. Serum PUFA were quantified in maternal blood collected at 28 weeks’ gestation and in cord blood collected at delivery. Birth weight was measured at delivery and classified according to WHO growth standards (n 1185). Child length/height (m) and weight (kg) were recorded at 20 months (n 1182), 7 (n 1167) and 13 (n 878) years. Child BMI was classified according to z-scores. Maternal total fish consumption (range: 0·0–584·71 g/d) was not associated with child weight at any age. At 7 and 13 years, maternal total n-6 PUFA were associated with increased risk of overweight/obesity (7 years; OR = 1·62, p = 0·037, 13 years; OR = 2·05, p = 0·005). Lower (<0·071 mg/ml) cord DHA concentrations were associated with a greater likelihood of being large for gestational age (LGA; >90th percentile) when compared with higher (>0·129 mg/ml) cord DHA concentrations (OR 4·17, p = 0·017). This study suggests that prenatal maternal n-3 and n-6 PUFA status may influence postnatal outcomes, including child adiposity from birth until adolescence.
Obesity and overweight in pregnant women increase pregnancy and neonatal morbidity with a risk of metabolic syndrome for children in later life. Maternal preconceptional bariatric surgery reduces maternal and paediatric outcomes but may induce fetal nutritional deficiencies and intrauterine growth restriction through placental reprogramming. The aim of this study was to describe feto-placental unit modifications induced by obesity, and the effect of bariatric surgery performed before gestation, on a diet-induced obese rat model. One month after surgery, rats of ‘control’, ‘obese’ and ‘bariatric surgery’ groups were mated and then sacrificed at D19 of gestation. Clinical description, immuno-histochemistry and molecular analyses were performed on feto-placental units. Obesity induces placental modifications including lipid accumulations, increased inflammation and oxidative stress. Some of these modifications are partially restored by maternal preconceptional bariatric surgery. On the other hand, a reduction in the expression of markers of glucose transport, insulin function and amino acid transport, after bariatric surgery was observed. This phenotype may lead to fetal caloric restriction, adoption of a ‘thrifty phenotype’ and subsequently fetal growth restriction. These preliminary findings highlight the importance of a close follow-up of women who have undergone bariatric surgery and their children.
To determine whether gestational vitamin D status modulates the effect of pre-pregnancy obesity on gestational diabetes mellitus (GDM) risk while stratifying by maternal age.
Design:
Birth cohort.
Setting:
A major maternity hospital in Kuwait.
Participants:
Pregnant women in their second/third trimester of gestation were enrolled. Pre-pregnancy BMI (kg/m2) was categorised as under/normal weight (< 25·0), overweight (25·0 to < 30·0) and obesity (≥ 30·0). Gestational 25-hydroxyvitamin D concentrations were categorised as deficiency (< 50 nmol/l) or insufficiency/sufficiency (≥ 50 nmol/l). GDM status was ascertained according to international guidelines. Adjusted OR (aOR) and 95 % CI were estimated using logistic regression.
Results:
Data from 957 pregnant women were analysed, with GDM affecting 166 (17·4 %) pregnancies. Pre-pregnancy obesity and gestational vitamin D deficiency were ascertained in 275 (28·7 %) and 533 (55·7 %) pregnant women, respectively. The association between pre-pregnancy obesity and GDM risk differed according to maternal age and gestational vitamin D status (Pinteraction[BMI × age × vitamin D] = 0·041). Among women aged < 35 years (n 710), pre-pregnancy obesity compared to under/normal weight was associated with increased GDM risk among women with gestational vitamin D deficiency (aOR: 2·72, 95 % CI: 1·18, 6·23) and vitamin D insufficiency/sufficiency (2·55, 1·15, 5·62). In contrast, among women aged ≥ 35 years (n 247), pre-pregnancy obesity compared to under/normal weight was associated with increased GDM risk among women with gestational vitamin D deficiency (6·92, 1·45, 33·04), but not among women with vitamin D insufficiency/sufficiency (1·13, 0·36, 3·56).
Conclusions:
Gestational vitamin D status modulates the effect of pre-pregnancy obesity on GDM risk in an age-specific manner.
It is widely recognised that weight stigma in news media is a problem, with selection of images, language, and news frames shown to contribute to negative and stereotypical representations. In response, several Australian, UK, and international organisations active in improving perceptions and treatment of people with obesity have published media guidelines. Some of these guidelines have been developed drawing on linguistic research or expertise and thus represent clear attempts at societal impact (changes in journalism practices, with presumed flow-on effects on policymaking, public perception, discourse, etc.). This chapter first reviews the recommendations that obesity media guidelines make, focusing specifically on language use. We show similarities and differences across six guidelines published for Australian, UK, and international contexts. Taking a corpus linguistic approach, we then examine to what extent selected advice on language choices from the guidelines is adhered to in journalism in Australia. We analyse dispreferred language (identity-first language and use of nominal-adjectival, the obese), preferred language (person-first language), and pejorative versus euphemistic labels. Focusing on people-first and identity-first language, we also include a comparison with a similar British corpus. The chapter concludes with critical reflections on application and impact, including the potential role of corpus linguistics in this area.
Veterans Affairs Medical Centers offer multiple weight-loss treatments, including a comprehensive lifestyle intervention program (i.e., MOVE!), anti-obesity medications (AOMs) and bariatric surgery. Yet, most eligible veterans do not receive these treatments.
Aim:
To describe the design, rationale, and planned evaluation of a comprehensive Weight Management and Metabolic Health program (WMMHP), consisting of (1) weight-focused visits with physicians or pharmacists trained in obesity medicine; (2) patient-centered use of available weight-loss treatments; and (3) coordinated, team-based care.
Methods:
This is a quality improvement program implemented within the VA Ann Arbor Healthcare System. WMMHP eligibility criteria include body mass index (BMI) ≥ 30 kg/m2 or BMI ≥ 27 kg/m2 and ≥ 1 weight-related condition and participation in the MOVE! program. We plan to conduct an 18-month retrospective program evaluation using a propensity-matched cohort analysis to estimate the added benefit of WMMHP vs. MOVE! alone. The primary outcome will be mean change in weight at 18 months after baseline. Secondary outcomes will include mean weight loss at 6, 12, and 24 months, percentage of patients achieving thresholds of ≥ 5%, ≥ 10%, and ≥ 15% weight loss, initial prescriptions for and refilled prescriptions as a measure of adherence to AOMs, and referrals to, engagement with, and completion of bariatric surgery. We will also examine between-group differences in health system resource utilization.
Discussion:
The WMMHP is an innovative approach to improving treatment and outcomes for veterans with overweight and obesity. If effective, its components may inform obesity care delivery in VA and non-VA settings.
In the UK academics are being urged to embrace interdisciplinarity in their research and teaching activities. In the case of public policy, there is a tension between the epistemological formations from the parent discipline of politics and garnering the benefits of interdisciplinarity. Furthermore, interdisciplinarity in public policy cannot and should not ignore cleavages in existing policy pathways. These concerns are discussed in the article by assessing the public policy of obesity in England and Wales.
This study investigated weight-related stigmatization in France using a mixed-methods approach with two aims: (1) to generate a systematic inventory of weight-related stigmatizing situations and (2) to examine how quality of life, self-esteem, and internalization of responsibility vary with BMI and sociodemographic factors (age, degree, and bariatric surgery). For the first objective, 252 French women reported a negative weight-related experience between September and December 2024, rated its emotional impact, and identified the source, form, and context of the stigma. For the second objective, 387 women and 63 men completed an online survey measuring attitudes (belief in a just world, self-esteem, and quality of life) and sociodemographic variables (gender, age, BMI, and degree). Qualitative analysis identified 484 stigmatizing incidents, categorized into eight themes. The most common were unpleasant verbal remarks (comments on appearance and weight, normative injunctions, and guilt-inducing statements), mainly from healthcare professionals. Most events occurred in private or semi-private settings such as homes or healthcare environments, often when the individual was alone with another person. Quantitative analyses revealed that greater stigma exposure, especially when paired with higher BMI, was linked to lower quality of life and, consequently, reduced self-esteem. Repeated stigmatization also led to a perception by people with obesity that, while the world is fair to others, it is unfair to them, further undermining their self-worth. These findings highlight the profound psychological toll of weight-related stigmatization and the need for more inclusive social and healthcare environments.
The global syndemic of obesity, undernutrition and climate change – three interconnected challenges – threatens both human and planetary health. This review focuses on one critical intersection: older populations living with overweight and obesity in the context of sustainable nutrition. Obesity and sarcopenia, particularly the co-occurrence called sarcopenic obesity, are often overlooked until the onset or exacerbation of other diseases necessitates secondary care. Preventing sarcopenic obesity requires reducing excess fat mass while preserving muscle mass and function. This involves lowering total energy intake while ensuring adequate protein intake in terms of quantity, quality and distribution, combined with physical activity, particularly resistance exercise. Short-term studies show that both the source and dose of dietary protein significantly influence muscle protein synthesis rates. Longer-term studies examining the impact of plant-based diets on muscle health in older adults with or without overweight or obesity remain limited. Animal protein have shown a modest advantage over most plant-based protein in supporting muscle mass. Qualitative studies suggest that emphasising both the health benefits and palatability of plant-based protein sources is key to promoting dietary changes in older adults. In older adults with obesity, it is challenging to combine energy restriction with higher protein intake, especially when protein sources are plant-based. To prevent and treat sarcopenic obesity in older adults and support planetary health, a shift toward more plant-based protein sources is required, while ensuring sufficient protein quantity and quality to preserve muscle health during weight loss.
Collagen supplementation (CS) has emerged as a promising therapeutic approach with potential benefits for managing metabolic syndrome (MetS)-related risk factors. This narrative review integrates human evidence with preclinical mechanistic insights into the metabolic actions of collagen. Anti-obesity effects are attributed to increased satiety, gastric distension, GLP-1 secretion and enhanced fatty acid oxidation mediated by PPAR-α activation and AMPK signalling. In type 2 diabetes, collagen improves glucose homeostasis by enhancing insulin sensitivity, upregulating GLUT-4 and inhibiting dipeptidyl peptidase IV (DPP-IV), thereby prolonging incretin activity (GLP-1 and GIP) and supporting β-cell function. The antihypertensive effect of collagen peptides (CP) is primarily linked to angiotensin-converting enzyme (ACE) inhibition, which reduces angiotensin II levels while promoting bradykinin-mediated vasodilation and nitric oxide release. In addition, CP has shown potential in improving lipid profiles by modulating PPAR-γ and AMPK, increasing HDL-C and reducing LDL-C and triacylglycerols. Emerging evidence also supports a role for collagen in restoring gut microbiota balance, increasing short-chain fatty acid production and reducing pro-inflammatory and oxidative pathways, contributing to systemic metabolic regulation. Overall, these findings suggest CS exerts multi-targeted benefits on MetS components through modulation of endocrine, inflammatory and metabolic pathways. Nevertheless, larger, long-term clinical trials are warranted to determine optimal dosing regimens, evaluate long-term efficacy, and further elucidate microbiota-mediated effects.
Obesity and depression are highly prevalent diseases that are strongly correlated. At the same time, there is a growing gap in care, and treatment options should be improved and extended. Positive effects of a Mediterranean diet on mental health have already been shown in various studies. In addition to the physiological effects of nutrients, the way food is eaten, such as mindful eating, seems to play a role. The present study investigates the effect of a Mediterranean diet and mindful eating on depression severity in people with clinically diagnosed major depressive disorder and obesity. Participants will be randomised to one of the four intervention groups (Mediterranean diet, mindful eating, their combination and a befriending control group). The factorial design allows investigating individual effects as well as potential synergistic effects of the interventions. The study consists of a 12-week intervention period, where five individual appointments will take place, followed by a 12-week follow-up. The primary outcome is depression severity. Secondary outcomes are remission of depression, assessor-rated depression severity, quality of life, self-efficacy, BMI, waist:hip ratio and body composition; adherence to the Mediterranean diet and mindful eating will also be assessed. Alongside mediator and moderator analysis, a microbiome analysis, a qualitative evaluation and an economic analysis will be conducted. The study investigates an important health issue in a vulnerable target group. It allows to draw valuable conclusions regarding the effectiveness of different interventions and therefore contributes to improving available care options for people suffering from depression and obesity.
To assess the prevalence and identify sociodemographic predictors of regular fast-food consumption (R-FFC) among United Arab Emirates (UAE) adults to inform public health nutrition responses to growing diet-related ill health in the region.
Design:
This is a descriptive cross-sectional study using purposive, convenience sampling. Data were collected using an online survey adapted from two validated surveys and distributed via social media platforms. R-FFC was defined as visiting a fast-food restaurant to eat ≥ 2 times/week. Pearson’s χ2 tests and multiple binary logistic regression models were used to investigate prevalence and predictors of R-FFC. All statistical significance was considered at P-value < 0·05.
Setting:
Community, adults living in the UAE.
Participants:
UAE residents, ≥ 18 years, who consumed fast food ≥ once during the previous month.
Results:
Totally, 320 respondents met the inclusion criteria (age = mean 23·7 (sd 7·7) years). The prevalence of R-FFC was 46·6 %. Based on results from the regression model, predictors of R-FFC were being female (AOR 2·47; 95 % CI 1·06, 5·79), married (AOR 3·11; 95 % CI 1·25, 7·77), BMI ≥ 25·0 (AOR 2·09; 95 % CI 1·10, 4·00) and residing outside Abu Dhabi (AOR 32·79; 95 % CI 12·06, 89·16). None of the remaining variables reached statistical significance. Taste was the most common reason for FFC (56·9 %), followed by convenience (21·6 %). Regular fast-food consumers were more likely to ‘super-size’ meals (P = 0·011), eat alone (P = 0·009) and not have regular meal patterns (P = 0·004).
Conclusions:
The study revealed a high prevalence of R-FFC among UAE adults, and novel cultural predictors and characteristics of FFC in this context, highlighting the importance of socially and culturally informed research and public health strategies in this region.
While the effects of multidisciplinary weight loss (WL) on resting energy expenditure remain unclear in adolescents with obesity, the potential presence of adaptive thermogenesis (AT) has never been explored, which was the objective of the present work. Twenty-six adolescents (14·1 (sd 1·5) years) with severe obesity completed a 9-month inpatient multidisciplinary intervention followed by a 4-month follow-up. Anthropometric measurements, body composition (dual X-ray absorptiometry) and resting energy expenditure (REE, indirect calorimetry) were assessed before (T0) and after 9 months of WL intervention (T1) and after a 4-month follow-up (T2). AT, at the level of REE, was defined as a significantly lower measured v. predicted (using regression models with baseline data) REE. Two pre-cited REE equations were used, using both fat mass and fat-free mass (FFM) (predicted REE using equation 1) or FFM only (predicted REE using equation 2). Measured and predicted REE significantly decreased between T0 and T1 (P < 0·001) and remained lower at T2 compared with T0 (measured REE: P = 0·017; predicted REE: P < 0·001). Predicted REE using equation 2 was significantly higher than measured REE at T1 (P = 0·012), suggesting the presence of AT. FFM at T0 was negatively correlated with ATp1T1 (Rho = –0·428; P = 0·033) and ATp2T1 (Rho = –0·485; P = 0·014). The variation of FFM between T0 and T1 was negatively correlated with AT at T1 and T2. These preliminary results suggest the existence of AT in response to WL in adolescents with obesity, independently of the degree of WL. AT was associated with subsequent body weight and fat regain, suggesting AT may represent a damper to WL attempts while increasing the adolescents’ risks for subsequent weight and adiposity rebounds.
This study investigates how the consumption of interesterified palm oil (IPO) affects the metabolic and morphological features of brown adipose tissue (BAT) in C57BL/6 mice fed a high-fat diet. Mice were divided into four groups: control, high-fat diet (lard), high-fat diet with palm oil (PO; HFP) and high-fat diet with IPO (HFI). The HFP and HFI groups exhibited significant body weight gain, increased fat mass and impaired glucose metabolism. Histological analyses revealed lipid infiltration in BAT, leading to structural remodelling from multilocular to unilocular adipocytes, which are hallmark features of the whitening process. This morphological shift was accompanied by reduced nuclear density and impaired vascularisation. Gene expression analysis indicated downregulation of key thermogenic markers, including Ucp1, Pparγ and Prdm16, especially in the HFI group. Increased expression of endoplasmic reticulum stress markers such as Chop and Atf4 and inflammatory cytokines (TNF-α and IL-6) highlighted the pro-inflammatory and pro-apoptotic microenvironment induced by PO and IPO. These changes culminated in a loss of BAT thermogenic capacity, as evidenced by decreased uncoupling protein 1 levels and impaired adaptive thermogenesis. Our findings underscore the detrimental effects of PO, mainly IPO, on BAT functionality, exacerbating obesity-related metabolic dysfunctions such as insulin resistance and glucose intolerance. The results emphasise the need for caution in the dietary use of these fats, particularly in ultra-processed food formulations, given their potential role in promoting adipose tissue remodelling and metabolic imbalances.
This chapter describes the development and validation of a body-image assessment tool, the BIAS-BD. The scale consists of 17 male and 17 female contour-line drawings based on known anthropometric body dimensions of shoulder, chest, waist, hip breadth, thigh breadth, and upper leg breadth. The drawings correspond to a series of body weights ranging from 60% below the documented average to 140% above average. Differences between drawings represent a 5% change in body weight. Participants select a drawing that reflects their perceived size and their ideal size. The discrepancy between perceived and ideal size is a measure of body dissatisfaction. Test-retest reliability over a 2 –week interval was r = .86 for actual perceived size, r = .72 for ideal size, and r = .76 for body dissatisfaction. All reliability values are significantly greater than 0. No significant differences in reliability values between genders were obtained. Concurrent validity, measured as the correspondence between perceived and report size, was r = .76. Unlike other scales, the present scale uses figural drawings based on known body dimensions and has superior reliability and validity. It avoids several problems inherent in existing contour-line drawing scales, including scale coarseness, the presence of ethnic facial and body features, and the lack of documented reliability and validity in most previously published scales.
This study aimed to develop and validate a questionnaire that investigates sugar-related eating behaviour, excessive consumption, and addictive-like eating. This questionnaire was validated using a rigorous process assessing content validity, face validity, reliability testing, feasibility testing, and construct validity. Spearman’s correlation coefficients and Cronbach’s alpha were used to assess reliability. Feasibility testing was used to further validate and confirm the scoring/categorisation of ‘low’, ‘medium’, and ‘high’ scorers for use in future research. Exploratory factor analysis and reliability analysis were used to determine underlying latent factors and assess construct validity. Content validity was assessed by health professionals (n = 16), face validity was assessed by the lay public who had no expertise in nutrition or addiction (n = 20). Reliability (n = 54), repeat reliability (n = 50), and feasibility (n = 113) testing were assessed with a sample from the lay public. Spearman’s correlation coefficients were in the range of 0.58–0.91 and were statistically significant (P < 0.001), indicating good temporal stability within the questionnaire. Cronbach’s alpha coefficients were in the range of 0.62–0.93, indicating good internal consistency. Feasibility testing confirmed the use of calculating an ‘average total score’ from the data set and splitting the data set into tertiles: low, medium, and high scorers. Exploratory factor analysis confirmed three latent factors: F1: Compulsive Eating; F2: Comfort Eating; and F3: Withdrawal. Results suggest the questionnaire is highly reliable and was successfully validated. This questionnaire can be used in research to investigate problematic and addictive-like eating behaviour and its effects on ill health.
Sub-Saharan Africa (SSA) is currently undergoing rapid urbanisation, a transition that is closely linked to the adoption of sedentary lifestyles and Westernised dietary habits. This shift has contributed to a substantial rise in obesity and diet-related non-communicable diseases (DR-NCDs), placing a significant strain on already burdened healthcare systems. Among the key modifiable risk factors driving this epidemiological transition are changes in dietary patterns. Western-style diets have been shown to promote inflammation and trigger metabolic and immune dysregulation, factors that underlie the development of DR-NCDs. Conversely, many Tanzanian heritage diets incorporate a diverse array of nutrient-rich foods prepared using techniques that minimise the use of oils, sweeteners and preservatives. These diets predominantly use whole grains, legumes and fruits, foods high in dietary fibre and nutraceuticals. Nutraceuticals are known to have both immunomodulatory and metabolic benefits and could potentially counteract the negative effects associated with Western-style diets. However, the limited scientific documentation of these heritage diets endangers future research into their potential health benefits. This underscores the need for targeted efforts to preserve and promote traditional dietary practices. In this review, we summarise the diversity of heritage diets from four distinct tribes in Northern Tanzania – the Maasai, Chagga, Pare and Hadzabe – who have historically exhibited low rates of DR-NCDs but are now experiencing rapid urbanisation and lifestyle changes. We briefly describe the dietary patterns of these tribes and examine the potential links between the declining usage of traditional dietary practices and the rising prevalence of DR-NCDs in Tanzania.